About Us
About EirGenix
Milestones
Vision and Mission
Facilities and Capacities
Xizhi Facility
Zhubei Facility
Management Team
Videos
360-Degree Virtual Tour
News
News
Events
Services
Cell Line Development
Process Development
Analytical & Quality Control
cGMP manufacturing–mammalian system
cGMP manufacturing–microbial system
Antibody-Drug Conjugate
Products
PRODUCT PIPELINE
CRM197 CARRIER PROTEIN
COVID-19 ANTIGEN RAPID TEST
Investor
Financials
Monthly Revenue
2023
2022
2021
2020
2019
2018
Financial Reports
2022
2021
2020
2019
2018
Corporate Governance
Corporate Governance
Board of Directors
Internal Audit
Shareholder Services
Shareholders' Meeting
Investor Conference
Dividend Distribution
Market Observation Post System
Investor Relations & Media Contact
Stock Transfer Agent
ESG
ESG Overview
Recruiting
Contact Us
|
English
|
繁體中文
EN
EN
繁中
×
LINKEDIN
YOUTUBE
Home
News
News
News
CANCER THERAPEUTIC DRUG EG12014 PASSED THE DOUBLE-BLINDED PHASE I CLINICAL TRIAL
2017/05/02
More
EIRGENIX RECEIVED "GRAND WINNER OF BEST BIOPROCESS EXCELLENCE IN TAIWAN"
2017/02/16
More
EIRGENIX HELD THE WHOLE NEW "PROTEIN DRUG COMMERCIAL PRODUCTION PLANT" GROUNDBREAKING CEREMONY
2016/12/30
More
2015 TAIWAN BIO-MEDICAL AND NEW AGRICULTURAL INDUSTRY DRAFT COMPETITION AWARDS CEREMONY
2015/09/24
More
EIRGENIX AND FORMOSA LABORATORIES COLLABORATE TO ESTABLISH A PLATFORM FOR ADC CMC INTEGRATION SERVIC
2014/06/23
More
EIRGENIX DEVELOPS AND MANUFACTURES BIOLOGICS
2013/12/06
More
‹
1
2
3
